Business Wire

Lineage Announces a Grand Prize of $50,000 for the Food Chain Innovation Challenge

5.9.2024 14:31:00 CEST | Business Wire | Press release

Share

The global winner will receive substantial prize from Lineage and invite to a six-month, executive-led incubator program to help kick start their business

Lineage, Inc. (NASDAQ: LINE) (the “Company”), the world’s largest global temperature-controlled warehouse REIT, today announced additional details of its flagship competition, the Food Chain Innovation Challenge, including members of the judging panels as well as the grand prize.

The challenge of creating impactful solutions for food waste comes at a critical time, as the severely food-insecure population is expected to hit nearly a billion people by 2028. Lineage’s global competition invites students and startups to pitch their innovative technologies or data solutions that address postharvest food waste.

The Food Chain Innovation Challenge will take place in three major locations: London on November 14, and Amsterdam and San Francisco both on November 19. Students, startups and other relevant candidates interested in participating can submit their applications online until September 30.

During each event, participants will present solutions aimed at mitigating food waste to an esteemed regional judging panel. Judges will select a regional winner, who will be awarded a $5,000 cash prize and a spot in the grand final event on December 2. One winner will then be chosen to receive the $50,000 grand prize and an invite into a six-month, executive-led incubator program tailored to their unique business goals.

London

The London event will take place on November 14, 2024, at The Science Museum. Lineage’s Regional Vice President, Clare Walters, will join a panel of distinguished judges including Simon Millard, Director of Food at FareShare; Harriet Lamb, CEO of WRAP; and Paul Randle, from the Cambridge Institute for Sustainable Leaders at Cambridge University. To support the aspiring innovators, ReLondon and FoodCycle are also partnering with the Food Chain Innovation Challenge to provide valuable insights and coaching as applicants refine their pitches.

Amsterdam

The Amsterdam event will take place on November 19, 2024, at The NEMO Science Museum. Lineage’s European President, Harld Peters, will join a panel of distinguished judges including Toine Timmermans, Director of Samen Tegen Voedselverspilling; Enno Masurel, Professor Doctor of Sustainable Entrepreneurship at the Free University Amsterdam; and Esteban Arriaga, CEO of FEBA (European Food Banks Federation).

San Francisco

The San Francisco event will take place on November 19, 2024, at the California Academy of Sciences. Lineage’s Global Chief Operations Officer Jeff Rivera will join a panel of distinguished judges, including Angel Veza, Capital, Innovation, & Engagement Senior Manager at ReFED; Danielle Todd, Founder and Executive Director at Make Food Not Waste; and Michael Wara, Director, Climate and Energy Policy Initiative at Stanford's Woods Institute for the Environment and Senior Director, Policy at the Sustainability Accelerator within the Stanford Doerr School of Sustainability.

Greg Lehmkuhl, President and CEO of Lineage, said: “Lineage is constantly looking at how we improve the global management of food storage, transportation and distribution. Beyond our own operational improvements, the Food Chain Innovation Challenge is a platform for us to support the industry's most promising talent and innovations. By collaborating, we can develop solutions that not only address food waste but also promote sustainable practices for the long term.”

Jeff Rivera, Global Chief Operations Officer at Lineage, added: “Despite producing enough food to feed the planet, hundreds of millions of people face food insecurity every day. At Lineage, we're dedicated to transforming the food supply chain to eliminate waste and feed the world. The Food Chain Innovation Challenge exemplifies this mission, and we’re excited to highlight new solutions and innovations while supporting these entrepreneurs' journeys to turn their ideas into reality.”

At the events, participants will be asked to pitch their existing ideas across four specific areas: reducing food waste, food preservation techniques, access to nutritious food and data-driven insights and analytics.

If you're interested in participating, apply here. For a glimpse into the 2023 Hackathon, the predecessor to The Food Chain Innovation Challenge held in Amsterdam, watch this video. Also, hear insights from last year's winner to get inspired and understand the impact of winning this prestigious challenge.

About Lineage

Lineage, Inc. (NASDAQ: LINE) is the world’s largest global temperature-controlled warehouse REIT with a network of over 480 strategically located facilities totaling over 84 million square feet and approximately 3.0 billion cubic feet of capacity across countries in North America, Europe, and Asia-Pacific. Coupling end-to-end supply chain solutions and technology, Lineage partners with some of the world’s largest food and beverage producers, retailers, and distributors to help increase distribution efficiency, advance sustainability, minimize supply chain waste, and, most importantly, feed the world. Learn more at onelineage.com and join us on LinkedIn, Facebook, Instagram, and X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240905272650/en/

Contacts

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release

Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release

A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release

New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release

Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release

Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye